SABBY MANAGEMENT, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 76 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$2,042,000
+310.9%
5,265,265
+3639.5%
2.57%
+13410.5%
Q3 2014$497,000
+25.2%
140,800
+196.4%
0.02%
+11.8%
Q2 2014$397,000
+52.7%
47,500
+15.9%
0.02%
+13.3%
Q1 2014$260,000
+60.5%
41,000
+80.2%
0.02%
+50.0%
Q4 2013$162,00022,7580.01%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Shilanski & Associates, Inc. 937,237$57,0000.02%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$57,0000.02%
CVA Family Office, LLC 1,137,920$69,0000.02%
Cypress Capital Management LLC (WY) 140,925$9,0000.01%
Helen Stephens Group, LLC 117,222$7,0000.01%
COURIER CAPITAL LLC 540,056$33,0000.00%
NORTHCAPE WEALTH MANAGEMENT, LLC 98,000$6,0000.00%
Newbridge Financial Services Group, Inc. 10,000$1,0000.00%
Western Wealth Management, LLC 352,950$11,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 606,800$37,0000.00%
View complete list of AMPIO PHARMACEUTICALS INC shareholders